Raw data for a meta-analysis concerning the second-line treatment of small cell lung caner

It remains unclear what the best second-line treatment is for patients with small-cell lung cancer (SCLC) sensitive to previous platinum-based chemotherapy. We performed a Bayesian network meta-analysis involving 1560 patients from 11 studies to identify the best second-line treatment for SCLC. We extracted raw data in this dataset.